Diomed Holdings, News - DIO

Diomed Holdings, Inc. to Host Conference Call Announcing Third Quarter 2006 Financial Results

Diomed Holdings, Inc. (AMEX: DIO), a leading developer and marketer of minimally invasive medical technologies, including its...

Diomed Holdings Completes $10 Million Equity Financing

Diomed Holdings, Inc. (AMEX: DIO), a leading developer and marketer of minimally invasive medical technologies, including its...

Court Rules in Favor of Diomed on Marked EVLT Sheath; Dismisses AngioDynamics' Declaratory Judgment

Diomed Holdings, Inc. (AMEX: DIO - News), a leading developer and marketer of minimally invasive medical technologies, including its patented...

Court Rules for Diomed; Diomed Wins Motion on Validity and Enforceability of EVLT(R) Patent; Trial on Infringement Expected

Diomed Holdings, Inc. (AMEX: DIO - News), a leading developer and marketer of minimally invasive medical technologies, including its patented...

Diomed Holdings, Inc. to Present at Roth Capital Partners 2006 New York Conference

Diomed Holdings, Inc. (AMEX: DIO), a leading developer and marketer of minimally-invasive medical technologies, including its patented EndoVenous...

Diomed Plan for Continued Listing Accepted by AMEX

Diomed Holdings, Inc. (AMEX: DIO), a leading developer and marketer of minimally invasive medical technologies, today announced that on August 3...

Diomed Holdings Signs $10 Million Equity Financing; Current Preferred Stock Holders to Tender Existing Shares for Shares of New

Diomed Holdings, Inc. (AMEX: DIO), a leading developer and marketer of minimally invasive medical technologies, including its patented EndoVenous...

Diomed Announces Record Second Quarter Results; Company Delivers 27% Growth in Total Revenues and 33% Increase in EVLT(R) Sales

Diomed Holdings, Inc. (AMEX: DIO), a leading developer and marketer of minimally invasive medical technologies, including its patented EVLT(R...

Diomed Holdings, Inc. to Host Conference Call and Announce Second Quarter 2006 Financial Results on Thursday, July 27, 2006

Diomed Holdings, Inc. (AMEX: DIO), a leading developer and marketer of minimally invasive medical technologies, including its patented EndoVenous...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Diomed Holdings, (DIO)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

DIO News

Diomed Holdings, Inc. to Host Conference Call Announcing Third Quarter 2006 Financial Results

Diomed Holdings Completes $10 Million Equity Financing

Court Rules in Favor of Diomed on Marked EVLT Sheath; Dismisses AngioDynamics' Declaratory Judgment

Court Rules for Diomed; Diomed Wins Motion on Validity and Enforceability of EVLT(R) Patent; Trial on Infringement Expected

Diomed Holdings, Inc. to Present at Roth Capital Partners 2006 New York Conference

Diomed Plan for Continued Listing Accepted by AMEX

Diomed Holdings Signs $10 Million Equity Financing; Current Preferred Stock Holders to Tender Existing Shares for Shares of New

Diomed Announces Record Second Quarter Results; Company Delivers 27% Growth in Total Revenues and 33% Increase in EVLT(R) Sales

Diomed Holdings, Inc. to Host Conference Call and Announce Second Quarter 2006 Financial Results on Thursday, July 27, 2006

Vascular Solutions and Diomed Settle Trade Secret and Sheath Marking Litigation

Diomed and Vascular Solutions Settle Trade Secret and Sheath Marking Litigation

Diomed Holdings, Inc. to Present at Jefferies Life Sciences Conference

Diomed Holdings Reports Notice Regarding AMEX Listing Standards

Diomed and BSN-JOBST Form Sales & Marketing Alliance

Diomed Announces Shipment of First VeinViewer Imaging Systems

DIO Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Diomed Holdings, (DIO) News

Diomed Holdings, (DIO)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

DIO News

Diomed Holdings, Inc. to Host Conference Call Announcing Third Quarter 2006 Financial Results

Diomed Holdings Completes $10 Million Equity Financing

Court Rules in Favor of Diomed on Marked EVLT Sheath; Dismisses AngioDynamics' Declaratory Judgment

Court Rules for Diomed; Diomed Wins Motion on Validity and Enforceability of EVLT(R) Patent; Trial on Infringement Expected

Diomed Holdings, Inc. to Present at Roth Capital Partners 2006 New York Conference

Diomed Plan for Continued Listing Accepted by AMEX

Diomed Holdings Signs $10 Million Equity Financing; Current Preferred Stock Holders to Tender Existing Shares for Shares of New

Diomed Announces Record Second Quarter Results; Company Delivers 27% Growth in Total Revenues and 33% Increase in EVLT(R) Sales

Diomed Holdings, Inc. to Host Conference Call and Announce Second Quarter 2006 Financial Results on Thursday, July 27, 2006

Vascular Solutions and Diomed Settle Trade Secret and Sheath Marking Litigation

Diomed and Vascular Solutions Settle Trade Secret and Sheath Marking Litigation

Diomed Holdings, Inc. to Present at Jefferies Life Sciences Conference

Diomed Holdings Reports Notice Regarding AMEX Listing Standards

Diomed and BSN-JOBST Form Sales & Marketing Alliance

Diomed Announces Shipment of First VeinViewer Imaging Systems

DIO Discussion

Your Recent History